Accelerating Vaccine Development through Use of Blood-Free Components
This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.
Scalable AAV Manufacturing: Addressing Challenges Across the Workflow
Sponsored by: Thermo Fisher ScientificIn this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows.
High-Throughput Proteomics During a Pandemic
In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application andlimitations of high-throughput timsTOF Pro mass spectrometry on large scale clinicalsample sets in order to stratify patients and contribute to a multi-omics blood atlasof COVID-19 patients, and the combination of laser capture microdissection withproteomics methods for the 3D characterization of large biological macrostructuressuch as organs or tumors.
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Sponsored by: WuXi AppTecIn this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.
AAV Based Gene Therapy for Rare Genetic Disorders: Strategies and Challenges
Sponsored by: WuXi AppTecIn this GEN webinar, sponsored by WuXi AppTec, we will review the challenges of utilizing AAV, as well as discuss in detail the recent progress and outstanding questions in AAV-based gene therapy.
